Advaxis, Inc. (NASDAQ:ADXS) represented a move of 1.09 percent or $-0.08 per share and closed its previous day trading session at $2.79. 696230 Shares were traded in the last trading session with an Average Volume of 816.85 Million Shares. The stock currently has a Market Capitalization of 117.65 Million.
Advaxis, Inc. is a development stage biotechnology company focused on developing safe and effective cancer vaccines that utilize multiple mechanisms of immunity. The Company is developing a live Listeria vaccine technology under license from the University of Pennsylvania which secretes a protein sequence containing a tumor-specific antigen. The Company believes this vaccine technology is capable of stimulating the body’s immune system to process and recognize the antigen as if it were foreign, generating an immune response able to attack the cancer. It also considers this to be a broadly enabling platform technology that can be applied to the treatment of many types of cancers, infectious diseases and auto-immune disorders. The Company’s products in development include Lovaxin C and Lovaxin B, Lovaxin P.
The stock traded between $ 2.43 and $10.06 over 1-Year time period showing its price to sales ratio of 9.8. Advaxis, Inc. (NASDAQ:ADXS) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-6.05 and 200-Day Simple Moving Average of $-45.61. Its Price to Free Cash Flow is 0 and Price to Book of 2.11.
Analyst’s recommended the stock as 1.5 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Advaxis, Inc. (NASDAQ:ADXS) reported its Actual EPS of $-0.57/share. The analysts offering Earnings Estimates for the company were believing that Advaxis, Inc. could bring EPS of $-0.55/share. The difference between Actual EPS and Estimated EPS was -0.02 Percent. Thus showing an Earnings Surprise of -3.6 Percent.
Aircastle LTD (NYSE:AYR)
In the last trading session, Aircastle LTD (NYSE:AYR) added its value by -1.45% closing at the price of $20.4. The stock currently has market capitalization of 1.61 Billion, with average volume of 266.45 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Aircastle LTD (NYSE:AYR) is showing beta of 1.65. This particular value of beta suggests that Aircastle LTD (NYSE:AYR) has historically moved 165% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Aircastle LTD (NYSE:AYR) is at $2.04.
The stock currently has RSI of 23.25. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
AIRCASTLE LTD are a global company that acquires and leases high utility commercial jet aircraft to passenger and cargo airlines throughout the world. High utility aircraft are generally modern, operationally efficient jets with a large operator base and long useful lives. They also make investments in other aviation assets, including debt securities secured by commercial jet aircraft.
Aircastle LTD (NYSE:AYR) topped its 52-week high price of $25.67 on 02/16/17 and 52-Week Low Price of $19.75 on 02/14/18. The Stock currently has P/E (price to earnings ttm) of 9.98 and Weekly volatility of 5.20% and monthly volatility of 3.02% respectively.